Copyright
©The Author(s) 2023.
World J Gastroenterol. Apr 14, 2023; 29(14): 2127-2133
Published online Apr 14, 2023. doi: 10.3748/wjg.v29.i14.2127
Published online Apr 14, 2023. doi: 10.3748/wjg.v29.i14.2127
Table 2 Proposed mechanisms of coronavirus disease 2019 cholangiopathy
| No. | Proposed pathogenesis of COVID-19 cholangiopathy |
| 1 | Cholangiocyte necrosis because of bile duct ischemia[24,25] |
| 2 | Micro thrombosis of hepatic sinusoids and ischemic injury[6] |
| 3 | Inflammation triggered due to cytokine release (cytokine release syndrome) |
| 4 | Direct virus mediated damage[11] |
| 5 | Drug induced liver injury in setting of severe COVID-19 infection (antibiotics, Remdesivir among others) |
| 6 | Ketamine related cholangiopathy in setting of COVID-19[14] |
- Citation: Yadlapati S, Jarrett SA, Baik D, Chaaya A. COVID-19 related biliary injury: A review of recent literature. World J Gastroenterol 2023; 29(14): 2127-2133
- URL: https://www.wjgnet.com/1007-9327/full/v29/i14/2127.htm
- DOI: https://dx.doi.org/10.3748/wjg.v29.i14.2127